250 related articles for article (PubMed ID: 7742153)
1. Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine.
Rasmussen BB; Maënpää J; Pelkonen O; Loft S; Poulsen HE; Lykkesfeldt J; Brøsen K
Br J Clin Pharmacol; 1995 Feb; 39(2):151-9. PubMed ID: 7742153
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine is a potent inhibitor of cytochrome P4501A2.
Brøsen K; Skjelbo E; Rasmussen BB; Poulsen HE; Loft S
Biochem Pharmacol; 1993 Mar; 45(6):1211-4. PubMed ID: 8466541
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.
Hemeryck A; De Vriendt C; Belpaire FM
Eur J Clin Pharmacol; 1999 Feb; 54(12):947-51. PubMed ID: 10192756
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.
Kobayashi K; Nakajima M; Oshima K; Shimada N; Yokoi T; Chiba K
Drug Metab Dispos; 1999 Aug; 27(8):860-5. PubMed ID: 10421611
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
von Moltke LL; Greenblatt DJ; Court MH; Duan SX; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine is a potent inhibitor of the metabolism of caffeine in vitro.
Rasmussen BB; Nielsen TL; Brøsen K
Pharmacol Toxicol; 1998 Dec; 83(6):240-5. PubMed ID: 9868741
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of imipramine metabolism by human liver microsomes.
Skjelbo E; Brøsen K
Br J Clin Pharmacol; 1992 Sep; 34(3):256-61. PubMed ID: 1389950
[TBL] [Abstract][Full Text] [Related]
9. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
10. O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants.
Fogelman SM; Schmider J; Venkatakrishnan K; von Moltke LL; Harmatz JS; Shader RI; Greenblatt DJ
Neuropsychopharmacology; 1999 May; 20(5):480-90. PubMed ID: 10192828
[TBL] [Abstract][Full Text] [Related]
11. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Kudchadker L; Fogelman SM; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010
[TBL] [Abstract][Full Text] [Related]
12. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: in vitro studies using human liver microsomes.
Hemeryck A; De Vriendt C; Belpaire FM
J Clin Psychopharmacol; 2000 Aug; 20(4):428-34. PubMed ID: 10917404
[TBL] [Abstract][Full Text] [Related]
14. Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors.
Murray M; Zhang WV; Edwards RJ
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):388-395. PubMed ID: 29155491
[TBL] [Abstract][Full Text] [Related]
15. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
Crewe HK; Lennard MS; Tucker GT; Woods FR; Haddock RE
Br J Clin Pharmacol; 1992 Sep; 34(3):262-5. PubMed ID: 1389951
[TBL] [Abstract][Full Text] [Related]
16. The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
Belpaire FM; Wijnant P; Temmerman A; Rasmussen BB; Brøsen K
Eur J Clin Pharmacol; 1998 May; 54(3):261-4. PubMed ID: 9681670
[TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro.
Wang JS; Backman JT; Wen X; Taavitsainen P; Neuvonen PJ; Kivistö KT
Pharmacol Toxicol; 1999 Nov; 85(5):201-5. PubMed ID: 10608481
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.
Lobo ED; Bergstrom RF; Reddy S; Quinlan T; Chappell J; Hong Q; Ring B; Knadler MP
Clin Pharmacokinet; 2008; 47(3):191-202. PubMed ID: 18307373
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.
Härtter S; Wang X; Weigmann H; Friedberg T; Arand M; Oesch F; Hiemke C
J Clin Psychopharmacol; 2001 Apr; 21(2):167-74. PubMed ID: 11270913
[TBL] [Abstract][Full Text] [Related]
20. Griseofulvin and fluvoxamine interactions with the metabolism of theophylline.
Rasmussen BB; Jeppesen U; Gaist D; Brøsen K
Ther Drug Monit; 1997 Feb; 19(1):56-62. PubMed ID: 9029748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
